New site helps answer questions regarding breast density notification, and efficacy, benefits, and harms of supplementary screening tests.
A new website can help clinicians navigate challenges introduced by the breast density notification laws, according to an article published in the journal Radiology.
On April 1, 2013, it became mandatory for physicians in California to notify, in writing, patients with dense breast tissue about their screening options.
“The legislation was prompted by breast cancer advocacy groups motivated to educate women regarding the limitations of mammography,” Jafi A. Lipson, MD, said in a release.
Lipson, an assistant professor of radiology at Stanford University School of Medicine in California, and colleagues from the California Breast Density Information group (CBDIG) developed the website. It’s an online document that answers frequently asked questions about the efficacy, benefits, and harm of supplementary screening tests.
Dense breast tissue can mask tumors, but the California law does not take into account the varying risk levels of individual patients, such as women who have the BRCA genetic mutation. One of the issues involved in additional breast cancer screening is the risk of increased false positives and benign breast biopsies, which could expose some patients to more harm than good.
Increased cost is another concern.
“While additional screening for women with extremely dense breasts could prove beneficial, supplemental screening of the approximately 40 percent of California women with heterogeneously dense breasts would result in a very substantial additional cost to the healthcare system,” Lipson pointed out.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
New Research Examines Socioeconomic Factors with Mammography No-Shows
April 10th 2024Patients with Medicaid or means-tested insurance were over 27 percent more likely to miss mammography appointments, and only 65 percent of women with three of more adverse social determinants of health had a mammography exam in a two-year period covering 2020 and 2021, according to new research and a report from the CDC.
Mammography Study: AI Improves Breast Cancer Detection and Reduces Reading Time with DBT
April 3rd 2024An emerging artificial intelligence (AI) model demonstrated more than 12 percent higher specificity and reduced image reading time by nearly six seconds in comparison to unassisted radiologist interpretation of digital breast tomosynthesis (DBT) images.